Ian Turner Buys 1,300,000 Shares of Radiopharm Theranostics Limited (ASX:RAD) Stock

Radiopharm Theranostics Limited (ASX:RAD) insider Ian Turner acquired 1,300,000 shares of the business’s stock in a transaction on Wednesday, February 19th. The shares were purchased at an average price of A$0.03 ($0.02) per share, for a total transaction of A$33,800.00 ($21,392.41).

Radiopharm Theranostics Stock Performance

The company has a market capitalization of $60.78 million, a P/E ratio of -0.19 and a beta of 0.82.

Radiopharm Theranostics Company Profile

Radiopharm Theranostics Limited engages in the research and development of radiopharmaceutical products for diagnostic and therapeutic uses in areas of high unmet medical needs. It is developing its lead products comprising Nano-mAbs and AVB6 Integrin. The company was incorporated in 2021 and is based in Carlton, Australia.